1,085 results on '"Receptors, Purinergic physiology"'
Search Results
2. Purinergic Signalling in Physiology and Pathophysiology.
- Author
-
Sluyter R
- Subjects
- Signal Transduction physiology, Adenosine Triphosphate physiology, Receptors, Purinergic physiology, Biological Phenomena
- Abstract
Since its inception by the late Geoffrey Burnstock in the early 1970s [...].
- Published
- 2023
- Full Text
- View/download PDF
3. Purinoceptor: a novel target for hypertension.
- Author
-
Li X, Zhu LJ, Lv J, and Cao X
- Subjects
- Humans, Receptors, Purinergic physiology, Synaptic Transmission, Signal Transduction, Adenosine Triphosphate physiology, Endothelial Cells, Hypertension
- Abstract
Hypertension is the leading cause of morbidity and mortality globally among all cardiovascular diseases. Purinergic signalling plays a crucial role in hypertension through the sympathetic nerve system, neurons in the brain stem, carotid body, endothelium, immune system, renin-angiotensin system, sodium excretion, epithelial sodium channel activity (ENaC), and renal autoregulation. Under hypertension, adenosine triphosphate (ATP) is released as a cotransmitter from the sympathetic nerve. It mediates vascular tone mainly through P2X1R activation on smooth muscle cells and activation of P2X4R and P2YR on endothelial cells and also via interaction with other purinoceptors, showing dual effects. P2Y1R is linked to neurogenic hypertension. P2X7R and P2Y11R are potential targets for immune-related hypertension. P2X3R located on the carotid body is the most promising novel therapeutic target for hypertension. A
1 R, A2A R, A2B R, and P2X7R are all related to renal autoregulation, which contribute to both renal damage and hypertension. The main focus is on the evidence addressing the involvement of purinoceptors in hypertension and therapeutic interventions., (© 2022. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
4. Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions.
- Author
-
Császár E, Lénárt N, Cserép C, Környei Z, Fekete R, Pósfai B, Balázsfi D, Hangya B, Schwarcz AD, Szabadits E, Szöllősi D, Szigeti K, Máthé D, West BL, Sviatkó K, Brás AR, Mariani JC, Kliewer A, Lenkei Z, Hricisák L, Benyó Z, Baranyi M, Sperlágh B, Menyhárt Á, Farkas E, and Dénes Á
- Subjects
- Adult, Aged, Animals, Brain physiology, Calcium Signaling physiology, Carotid Artery Diseases physiopathology, Evoked Potentials physiology, Female, Humans, Hypercapnia physiopathology, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Purinergic P2Y12 physiology, Vasodilation physiology, Vibrissae innervation, Cerebrovascular Circulation physiology, Microglia physiology, Neurovascular Coupling physiology, Receptors, Purinergic physiology
- Abstract
Microglia, the main immunocompetent cells of the brain, regulate neuronal function, but their contribution to cerebral blood flow (CBF) regulation has remained elusive. Here, we identify microglia as important modulators of CBF both under physiological conditions and during hypoperfusion. Microglia establish direct, dynamic purinergic contacts with cells in the neurovascular unit that shape CBF in both mice and humans. Surprisingly, the absence of microglia or blockade of microglial P2Y12 receptor (P2Y12R) substantially impairs neurovascular coupling in mice, which is reiterated by chemogenetically induced microglial dysfunction associated with impaired ATP sensitivity. Hypercapnia induces rapid microglial calcium changes, P2Y12R-mediated formation of perivascular phylopodia, and microglial adenosine production, while depletion of microglia reduces brain pH and impairs hypercapnia-induced vasodilation. Microglial actions modulate vascular cyclic GMP levels but are partially independent of nitric oxide. Finally, microglial dysfunction markedly impairs P2Y12R-mediated cerebrovascular adaptation to common carotid artery occlusion resulting in hypoperfusion. Thus, our data reveal a previously unrecognized role for microglia in CBF regulation, with broad implications for common neurological diseases., Competing Interests: Disclosures: D. Máthé reported grants from European Union H2020 HCEMM-739593 and from NRDIO, Hungary, TKP-BIOImaging-2020-4.1.1-TKP2020 during the conduct of the study. D. Máthé is CEO and stakeholder of CROmed Ltd. Z. Lenkei reported personal fees from Iconeus outside the submitted work. No other disclosures were reported., (© 2022 Császár et al.)
- Published
- 2022
- Full Text
- View/download PDF
5. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
- Author
-
Hasan D, Shono A, van Kalken CK, van der Spek PJ, Krenning EP, and Kotani T
- Subjects
- Anti-Inflammatory Agents therapeutic use, Critical Care, Cytokine Release Syndrome drug therapy, Humans, Inflammation drug therapy, Infusions, Subcutaneous, Lidocaine administration & dosage, Lidocaine pharmacology, Lymph Nodes immunology, Lymphatic System immunology, Male, Maximum Tolerated Dose, Middle Aged, Models, Immunological, Purinergic P2X Receptor Antagonists administration & dosage, Purinergic P2X Receptor Antagonists pharmacology, Receptors, Purinergic drug effects, Receptors, Purinergic P1 drug effects, Receptors, Purinergic P1 physiology, Receptors, Purinergic P2X7 physiology, Respiratory Distress Syndrome drug therapy, Respiratory Distress Syndrome etiology, Signal Transduction, T-Lymphocytes, Regulatory immunology, Adenosine Triphosphate metabolism, COVID-19 immunology, Cytokine Release Syndrome etiology, Inflammation etiology, Lidocaine therapeutic use, Purinergic P2X Receptor Antagonists therapeutic use, Receptors, Purinergic physiology
- Abstract
Hyperinflammation plays an important role in severe and critical COVID-19. Using inconsistent criteria, many researchers define hyperinflammation as a form of very severe inflammation with cytokine storm. Therefore, COVID-19 patients are treated with anti-inflammatory drugs. These drugs appear to be less efficacious than expected and are sometimes accompanied by serious adverse effects. SARS-CoV-2 promotes cellular ATP release. Increased levels of extracellular ATP activate the purinergic receptors of the immune cells initiating the physiologic pro-inflammatory immune response. Persisting viral infection drives the ATP release even further leading to the activation of the P2X7 purinergic receptors (P2X7Rs) and a severe yet physiologic inflammation. Disease progression promotes prolonged vigorous activation of the P2X7R causing cell death and uncontrolled ATP release leading to cytokine storm and desensitisation of all other purinergic receptors of the immune cells. This results in immune paralysis with co-infections or secondary infections. We refer to this pathologic condition as hyperinflammation. The readily available and affordable P2X7R antagonist lidocaine can abrogate hyperinflammation and restore the normal immune function. The issue is that the half-maximal effective concentration for P2X7R inhibition of lidocaine is much higher than the maximal tolerable plasma concentration where adverse effects start to develop. To overcome this, we selectively inhibit the P2X7Rs of the immune cells of the lymphatic system inducing clonal expansion of Tregs in local lymph nodes. Subsequently, these Tregs migrate throughout the body exerting anti-inflammatory activities suppressing systemic and (distant) local hyperinflammation. We illustrate this with six critically ill COVID-19 patients treated with lidocaine., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
6. Pannexin Channel Regulation of Cell Migration: Focus on Immune Cells.
- Author
-
Harcha PA, López-López T, Palacios AG, and Sáez PJ
- Subjects
- Adenine Nucleotides physiology, Aging immunology, Aging physiology, Animals, Astrocytes physiology, Cell Polarity, Chemotaxis, Leukocyte physiology, Cytoskeleton physiology, Fibroblasts physiology, Humans, Inflammation immunology, Inflammation physiopathology, Keratinocytes physiology, Mechanotransduction, Cellular physiology, Neoplasms immunology, Nerve Degeneration immunology, Nerve Degeneration physiopathology, Nerve Tissue Proteins physiology, Receptors, Purinergic physiology, Cell Movement physiology, Connexins physiology, Dendritic Cells physiology, Leukocytes physiology, Phagocytes physiology
- Abstract
The role of Pannexin (PANX) channels during collective and single cell migration is increasingly recognized. Amongst many functions that are relevant to cell migration, here we focus on the role of PANX-mediated adenine nucleotide release and associated autocrine and paracrine signaling. We also summarize the contribution of PANXs with the cytoskeleton, which is also key regulator of cell migration. PANXs, as mechanosensitive ATP releasing channels, provide a unique link between cell migration and purinergic communication. The functional association with several purinergic receptors, together with a plethora of signals that modulate their opening, allows PANX channels to integrate physical and chemical cues during inflammation. Ubiquitously expressed in almost all immune cells, PANX1 opening has been reported in different immunological contexts. Immune activation is the epitome coordination between cell communication and migration, as leukocytes (i.e., T cells, dendritic cells) exchange information while migrating towards the injury site. In the current review, we summarized the contribution of PANX channels during immune cell migration and recruitment; although we also compile the available evidence for non-immune cells (including fibroblasts, keratinocytes, astrocytes, and cancer cells). Finally, we discuss the current evidence of PANX1 and PANX3 channels as a both positive and/or negative regulator in different inflammatory conditions, proposing a general mechanism of these channels contribution during cell migration., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Harcha, López-López, Palacios and Sáez.)
- Published
- 2021
- Full Text
- View/download PDF
7. Purinergic Signaling in the Regulation of Gout Flare and Resolution.
- Author
-
Li X, Gao J, and Tao J
- Subjects
- Adenosine Triphosphate metabolism, Antigens, CD physiology, Apyrase physiology, Gout physiopathology, Humans, NLR Family, Pyrin Domain-Containing 3 Protein physiology, Receptors, Purinergic classification, Receptors, Purinergic P2Y physiology, Signal Transduction physiology, Gout etiology, Receptors, Purinergic physiology
- Abstract
Gout flares require monosodium urate (MSU) to activate the NLRP3 inflammasome and secrete sufficient IL-1β. However, MSU alone is not sufficient to cause a flare. This is supported by the evidence that most patients with hyperuricemia do not develop gout throughout their lives. Recent studies have shown that, besides MSU, various purine metabolites, including adenosine triphosphate, adenosine diphosphate, and adenosine bind to different purine receptors for regulating IL-1β secretion implicated in the pathogenesis of gout flares. Purine metabolites such as adenosine triphosphate mainly activate the NLRP3 inflammasome through P2X ion channel receptors, which stimulates IL-1β secretion and induces gout flares, while some purine metabolites such as adenosine diphosphate and adenosine mainly act on the G protein-coupled receptors exerting pro-inflammatory or anti-inflammatory effects to regulate the onset and resolution of a gout flare. Given that the purine signaling pathway exerts different regulatory effects on inflammation and that, during the inflammatory process of a gout flare, an altered expression of purine metabolites and their receptors was observed in response to the changes in the internal environment. Thus, the purine signaling pathway is involved in regulating gout flare and resolution. This study was conducted to review and elucidate the role of various purine metabolites and purinergic receptors during the process., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Li, Gao and Tao.)
- Published
- 2021
- Full Text
- View/download PDF
8. Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue.
- Author
-
Leão Batista Simões J, Fornari Basso H, Cristine Kosvoski G, Gavioli J, Marafon F, Elias Assmann C, Barbosa Carvalho F, and Dulce Bagatini M
- Subjects
- Adenosine Triphosphate physiology, Humans, Inflammation etiology, Receptors, Purinergic physiology, Severity of Illness Index, Signal Transduction physiology, COVID-19 immunology, Cytokine Release Syndrome drug therapy, Receptors, Purinergic drug effects, SARS-CoV-2
- Abstract
The etiological agent of coronavirus disease (COVID-19) is the new member of the Coronaviridae family, a severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2), responsible for the pandemic that is plaguing the world. The single-stranded RNA virus is capable of infecting the respiratory tract, by binding the spike (S) protein on its viral surface to receptors for the angiotensin II-converting enzyme (ACE2), highly expressed in the pulmonary tissue, enabling the interaction of the virus with alveolar epithelial cells promoting endocytosis and replication of viral material. The infection triggers the activation of the immune system, increased purinergic signaling, and the release of cytokines as a defense mechanism, but the response can become exaggerated and prompt the so-called "cytokine storm", developing cases such as severe acute respiratory syndrome (SARS). This is characterized by fever, cough, and difficulty breathing, which can progress to pneumonia, failure of different organs and death. Thus, the present review aims to compile and correlate the mechanisms involved between the immune and purinergic systems with COVID-19, since the modulation of purinergic receptors, such as A2A, A2B, and P2X7 expressed by immune cells, seems to be effective as a promising therapy, to reduce the severity of the disease, as well as aid in the treatment of acute lung diseases and other cases of generalized inflammation., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
9. A novel mechanism of rotavirus infection involving purinergic signaling.
- Author
-
Morales-Soto W and Gulbransen BD
- Subjects
- Animals, Child, Diarrhea drug therapy, Diarrhea etiology, Humans, Receptors, Purinergic physiology, Rotavirus Infections drug therapy, Signal Transduction drug effects
- Published
- 2021
- Full Text
- View/download PDF
10. Adenosine kinase: A key regulator of purinergic physiology.
- Author
-
Boison D and Jarvis MF
- Subjects
- Adenosine Kinase antagonists & inhibitors, Animals, Enzyme Inhibitors administration & dosage, Humans, Purinergic Agonists administration & dosage, Purinergic Antagonists administration & dosage, Adenosine Kinase physiology, Receptors, Purinergic physiology, Receptors, Purinergic P1 physiology
- Abstract
Adenosine (ADO) is an essential biomolecule for life that provides critical regulation of energy utilization and homeostasis. Adenosine kinase (ADK) is an evolutionary ancient ribokinase derived from bacterial sugar kinases that is widely expressed in all forms of life, tissues and organ systems that tightly regulates intracellular and extracellular ADO concentrations. The facile ability of ADK to alter ADO availability provides a "site and event" specificity to the endogenous protective effects of ADO in situations of cellular stress. In addition to modulating the ability of ADO to activate its cognate receptors (P1 receptors), nuclear ADK isoform activity has been linked to epigenetic mechanisms based on transmethylation pathways. Previous drug discovery research has targeted ADK inhibition as a therapeutic approach to manage epilepsy, pain, and inflammation. These efforts generated multiple classes of highly potent and selective inhibitors. However, clinical development of early ADK inhibitors was stopped due to apparent mechanistic toxicity and the lack of suitable translational markers. New insights regarding the potential role of the nuclear ADK isoform (ADK-Long) in the epigenetic modulation of maladaptive DNA methylation offers the possibility of identifying novel ADK-isoform selective inhibitors and new interventional strategies that are independent of ADO receptor activation., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. New Horizons: Does Mineralocorticoid Receptor Activation by Cortisol Cause ATP Release and COVID-19 Complications?
- Author
-
Edwards C
- Subjects
- Angiotensin-Converting Enzyme 2 physiology, Blood Coagulation Disorders etiology, Blood Coagulation Disorders metabolism, Blood Coagulation Disorders virology, COVID-19 metabolism, COVID-19 pathology, Dexamethasone therapeutic use, Eplerenone therapeutic use, Humans, Hydrocortisone adverse effects, Hydrocortisone metabolism, Mineralocorticoid Receptor Antagonists therapeutic use, Models, Biological, Paracrine Communication drug effects, Receptors, Mineralocorticoid metabolism, Receptors, Purinergic physiology, Respiratory Distress Syndrome complications, Respiratory Distress Syndrome metabolism, Respiratory Distress Syndrome virology, SARS-CoV-2 drug effects, SARS-CoV-2 pathogenicity, Severity of Illness Index, Spironolactone therapeutic use, COVID-19 Drug Treatment, Adenosine Triphosphate metabolism, COVID-19 complications, Hydrocortisone pharmacology, Receptors, Mineralocorticoid agonists
- Abstract
This paper attempts to explain how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus causes the complications that make coronavirus disease 2019 (COVID-19) a serious disease in specific patient subgroups. It suggests that cortisol-associated activation of the mineralocorticoid receptor (MR) in epithelial and endothelial cells infected with the virus stimulates the release of adenosine 5'-triphosphate (ATP), which then acts back on purinergic receptors. In the lung this could produce the nonproductive cough via purinergic P2X3 receptors on vagal afferent nerves. In endothelial cells it could stimulate exocytosis of Weibel-Palade bodies (WPBs) that contain angiopoietin-2, which is important in the pathogenesis of acute respiratory distress syndrome (ARDS) by increasing capillary permeability and von Willebrand factor (VWF), which mediates platelet adhesion to the endothelium and hence clotting. Angiopoietin-2 and VWF levels both are markedly elevated in COVID-19-associated ARDS. This paper offers an explanation for the sex differences in SARS-CoV-2 complications and also for why these are strongly associated with age, race, diabetes, and body mass index. It also explains why individuals with blood group A have a higher risk of severe infection than those with blood group O. Dexamethasone has been shown to be of benefit in coronavirus ARDS patients and has been thought to act as an anti-inflammatory drug. This paper suggests that a major part of its effect may be due to suppression of cortisol secretion. There is an urgent need to trial the combination of dexamethasone and an MR antagonist such as spironolactone to more effectively block the MR and hence the exocytosis of WPBs., (© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.)
- Published
- 2021
- Full Text
- View/download PDF
12. The retrotrapezoid nucleus and the neuromodulation of breathing.
- Author
-
Moreira TS, Sobrinho CR, Falquetto B, Oliveira LM, Lima JD, Mulkey DK, and Takakura AC
- Subjects
- Adenosine Triphosphate physiology, Animals, Cholinergic Neurons physiology, Humans, Medulla Oblongata cytology, Receptors, Purinergic physiology, Respiration, Serotonergic Neurons physiology, Chemoreceptor Cells physiology, Medulla Oblongata physiology, Receptors, Neurotransmitter physiology, Respiratory Mechanics physiology
- Abstract
Breathing is regulated by a host of arousal and sleep-wake state-dependent neuromodulators to maintain respiratory homeostasis. Modulators such as acetylcholine, norepinephrine, histamine, serotonin (5-HT), adenosine triphosphate (ATP), substance P, somatostatin, bombesin, orexin, and leptin can serve complementary or off-setting functions depending on the target cell type and signaling mechanisms engaged. Abnormalities in any of these modulatory mechanisms can destabilize breathing, suggesting that modulatory mechanisms are not overly redundant but rather work in concert to maintain stable respiratory output. The present review focuses on the modulation of a specific cluster of neurons located in the ventral medullary surface, named retrotrapezoid nucleus, that are activated by changes in tissue CO
2 /H+ and regulate several aspects of breathing, including inspiration and active expiration.- Published
- 2021
- Full Text
- View/download PDF
13. Purinergic Signaling Controls Spontaneous Activity in the Auditory System throughout Early Development.
- Author
-
Babola TA, Li S, Wang Z, Kersbergen CJ, Elgoyhen AB, Coate TM, and Bergles DE
- Subjects
- Adenosine Triphosphate metabolism, Animals, Calcium Signaling physiology, Cochlea growth & development, Cochlea physiology, Female, Hair Cells, Auditory physiology, Hair Cells, Auditory, Inner physiology, Inferior Colliculi physiology, Labyrinth Supporting Cells physiology, Male, Mice, Parasympathetic Nervous System drug effects, Parasympathetic Nervous System physiology, Purinergic P2Y Receptor Antagonists pharmacology, Receptors, Purinergic P2Y1 physiology, Retina physiology, Spiral Ganglion physiology, Auditory Pathways growth & development, Auditory Pathways physiology, Receptors, Purinergic physiology
- Abstract
Spontaneous bursts of electrical activity in the developing auditory system arise within the cochlea before hearing onset and propagate through future sound-processing circuits of the brain to promote maturation of auditory neurons. Studies in isolated cochleae revealed that this intrinsically generated activity is initiated by ATP release from inner supporting cells (ISCs), resulting in activation of purinergic autoreceptors, K
+ efflux, and subsequent depolarization of inner hair cells. However, it is unknown when this activity emerges or whether different mechanisms induce activity during distinct stages of development. Here we show that spontaneous electrical activity in mouse cochlea from both sexes emerges within ISCs during the late embryonic period, preceding the onset of spontaneous correlated activity in inner hair cells and spiral ganglion neurons, which begins at birth and follows a base to apex developmental gradient. At all developmental ages, pharmacological inhibition of P2Y1 purinergic receptors dramatically reduced spontaneous activity in these three cell types. Moreover, in vivo imaging within the inferior colliculus revealed that auditory neurons within future isofrequency zones exhibit coordinated neural activity at birth. The frequency of these discrete bursts increased progressively during the postnatal prehearing period yet remained dependent on P2RY1. Analysis of mice with disrupted cholinergic signaling in the cochlea indicate that this efferent input modulates, rather than initiates, spontaneous activity before hearing onset. Thus, the auditory system uses a consistent mechanism involving ATP release from ISCs and activation of P2RY1 autoreceptors to elicit coordinated excitation of neurons that will process similar frequencies of sound. SIGNIFICANCE STATEMENT In developing sensory systems, groups of neurons that will process information from similar sensory space exhibit highly correlated electrical activity that is critical for proper maturation and circuit refinement. Defining the period when this activity is present, the mechanisms responsible and the features of this activity are crucial for understanding how spontaneous activity influences circuit development. We show that, from birth to hearing onset, the auditory system relies on a consistent mechanism to elicit correlate firing of neurons that will process similar frequencies of sound. Targeted disruption of this activity will increase our understanding of how these early circuits mature and may provide insight into processes responsible for developmental disorders of the auditory system., (Copyright © 2021 the authors.)- Published
- 2021
- Full Text
- View/download PDF
14. Purinergic Dysfunction in Pulmonary Arterial Hypertension.
- Author
-
Cai Z, Tu L, Guignabert C, Merkus D, and Zhou Z
- Subjects
- Animals, Humans, Pulmonary Arterial Hypertension physiopathology, Purinergic Agents pharmacology, Receptors, Purinergic drug effects, Receptors, Purinergic physiology, Pulmonary Arterial Hypertension metabolism, Receptors, Purinergic metabolism
- Abstract
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by increased pulmonary arterial pressure and pulmonary vascular resistance, which result in an increase in afterload imposed onto the right ventricle, leading to right heart failure. Current therapies are incapable of reversing the disease progression. Thus, the identification of novel and potential therapeutic targets is urgently needed. An alteration of nucleotide- and nucleoside-activated purinergic signaling has been proposed as a potential contributor in the pathogenesis of PAH. Adenosine-mediated purinergic 1 receptor activation, particularly A
2A R activation, reduces pulmonary vascular resistance and attenuates pulmonary vascular remodeling and right ventricle hypertrophy, thereby exerting a protective effect. Conversely, A2B R activation induces pulmonary vascular remodeling, and is therefore deleterious. ATP-mediated P2X7 R activation and ADP-mediated activation of P2Y1 R and P2Y12 R play a role in pulmonary vascular tone, vascular remodeling, and inflammation in PAH. Recent studies have revealed a role of ectonucleotidase nucleoside triphosphate diphosphohydrolase, that degrades ATP/ADP, in regulation of pulmonary vascular remodeling. Interestingly, existing evidence that adenosine activates erythrocyte A2B R signaling, counteracting hypoxia-induced pulmonary injury, and that ATP release is impaired in erythrocyte in PAH implies erythrocyte dysfunction as an important trigger to affect purinergic signaling for pathogenesis of PAH. The present review focuses on current knowledge on alteration of nucleot(s)ide-mediated purinergic signaling as a potential disease mechanism underlying the development of PAH.- Published
- 2020
- Full Text
- View/download PDF
15. The Role of Purinergic Receptors in the Circadian System.
- Author
-
Ali AAH, Avakian GA, and Gall CV
- Subjects
- Animals, Humans, Hypothalamus cytology, Hypothalamus physiology, Models, Neurological, Neurons cytology, Suprachiasmatic Nucleus cytology, Circadian Clocks physiology, Circadian Rhythm physiology, Neurons physiology, Receptors, Purinergic physiology, Signal Transduction physiology, Suprachiasmatic Nucleus physiology
- Abstract
The circadian system is an internal time-keeping system that synchronizes the behavior and physiology of an organism to the 24 h solar day. The master circadian clock, the suprachiasmatic nucleus (SCN), resides in the hypothalamus. It receives information about the environmental light/dark conditions through the eyes and orchestrates peripheral oscillators. Purinergic signaling is mediated by extracellular purines and pyrimidines that bind to purinergic receptors and regulate multiple body functions. In this review, we highlight the interaction between the circadian system and purinergic signaling to provide a better understanding of rhythmic body functions under physiological and pathological conditions., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2020
- Full Text
- View/download PDF
16. [Purinergic receptors and hepatic fibrosis].
- Author
-
Chouiter A, Dali AR, and Dellis O
- Subjects
- Animals, Calcium Signaling genetics, End Stage Liver Disease genetics, End Stage Liver Disease therapy, Exocytosis genetics, Humans, Liver metabolism, Liver pathology, Molecular Targeted Therapy methods, Molecular Targeted Therapy trends, Myofibroblasts metabolism, Myofibroblasts pathology, Protein Transport genetics, Receptors, Purinergic P2X4 physiology, Liver Cirrhosis genetics, Liver Cirrhosis metabolism, Liver Cirrhosis pathology, Liver Cirrhosis therapy, Receptors, Purinergic physiology
- Published
- 2020
- Full Text
- View/download PDF
17. Agonists and Antagonists for Purinergic Receptors.
- Author
-
Müller CE, Baqi Y, and Namasivayam V
- Subjects
- Animals, Humans, Signal Transduction, Adenosine Triphosphate metabolism, Purinergic P2 Receptor Agonists pharmacology, Purinergic P2 Receptor Antagonists pharmacology, Receptors, Purinergic chemistry, Receptors, Purinergic physiology
- Abstract
Membrane receptors that are activated by the purine nucleoside adenosine (adenosine receptors) or by purine or pyrimidine nucleotides (P2Y and P2X receptors) transduce extracellular signals to the cytosol. They play important roles in physiology and disease. The G protein-coupled adenosine receptors comprise four subtypes: A
1 , A2A , A2B , and A3 . The G-protein-coupled P2Y receptors are subdivided into eight subtypes: P2Y1 , P2Y2 , P2Y4 , P2Y6 , P2Y11 , P2Y12 , P2Y13 , and P2Y14 , while the P2X receptors represent ATP-gated homomeric or heteromeric ion channels consisting of three subunits; the most important subunits are P2X1, P2X2, P2X3, P2X4, and P2X7. This chapter provides guidance for selecting suitable tool compounds for studying these large and important purine receptor families.- Published
- 2020
- Full Text
- View/download PDF
18. Assays to Measure Purinoceptor Pore Dilation.
- Author
-
Gu BJ, Avula P, and Wiley JS
- Subjects
- Animals, Biological Assay, Humans, Ion Transport, Adenosine Triphosphate metabolism, Calcium metabolism, Ethidium metabolism, Flow Cytometry methods, Ion Channels physiology, Receptors, Purinergic physiology
- Abstract
The P2X7 receptor is a classic purinoceptor/ion channel. After activated by ATP, it opens a cation selective channel, which dilates to a large pore over tens of seconds, allowing the entry of big molecules. This unique feature is often used to evaluate this receptor's function with DNA-binding dyes (MW 300-400 Da), such as ethidium bromide and Yo-Pro-1. Here we describe two-color flow cytometry based protocols for measuring P2X7 pore dilation. One is ATP-induced ethidium uptake by real-time multicolor flow cytometry for standardized and accurate quantitation, and the other is a quick whole blood assay which is particularly useful for ex vivo study.
- Published
- 2020
- Full Text
- View/download PDF
19. Purinergic receptors in neurogenic processes.
- Author
-
Ribeiro DE, Glaser T, Oliveira-Giacomelli Á, and Ulrich H
- Subjects
- Adenosine Triphosphate, Animals, Brain cytology, Calcium metabolism, Calcium Signaling, Cell Differentiation, Cell Proliferation, Hippocampus cytology, Humans, Nervous System, Purines metabolism, Receptors, Purinergic P2X7 metabolism, Receptors, Purinergic P2Y1 metabolism, Signal Transduction physiology, Neurogenesis physiology, Receptors, Purinergic metabolism, Receptors, Purinergic physiology
- Abstract
Neurogenesis is a process of generating functional neurons, which occurs during embryonic and adult stages in mammals. While neurogenesis during development phase is characterized by intensive proliferation activity in all regions of the brain to form the architecture and neural function of the nervous system, adult neurogenesis occurs with less intensity in two brain regions and is involved in the maintenance of neurogenic niches, local repair, memory and cognitive functions in the hippocampus. Taking such differences into account, the understanding of molecular mechanisms involved in cell differentiation in developmental stages and maintenance of the nervous system is an important research target. Although embryonic and adult neurogenesis presents several differences, signaling through purinergic receptors participates in this process throughout life. For instance, while embryonic neurogenesis involves P2X7 receptor down-regulation and calcium waves triggered by P2Y1 receptor stimulation, adult neurogenesis may be enhanced by increased activity of A
2A and P2Y1 receptors and impaired by A1 , P2Y13 and P2X7 receptor stimulation., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
20. Purinergic signaling in Alzheimer's disease.
- Author
-
Erb L, Woods LT, Khalafalla MG, and Weisman GA
- Subjects
- Adenosine Triphosphate, Alzheimer Disease pathology, Animals, Central Nervous System physiology, Disease Models, Animal, Humans, Plaque, Amyloid metabolism, Purines metabolism, Receptors, Purinergic P1 metabolism, Receptors, Purinergic P2X metabolism, Receptors, Purinergic P2Y metabolism, Signal Transduction physiology, Alzheimer Disease metabolism, Receptors, Purinergic metabolism, Receptors, Purinergic physiology
- Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by three major histopathological markers: amyloid-β (Aβ) plaques, neurofibrillary tangles and gliosis in the central nervous system (CNS). It is now accepted that neuroinflammatory events in the CNS play a crucial role in the development of AD. This review focuses on neuroinflammatory signaling mediated by purinergic receptors (P1 adenosine receptors, P2X ATP-gated ion channels and G protein-coupled P2Y nucleotide receptors) and how therapeutic modulation of purinergic signaling influences disease progression in AD patients and animal models of AD., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
21. Purinergic signaling as a target for emerging neurotherapeutics.
- Author
-
Engel T and Sperlagh B
- Subjects
- Adenosine Triphosphate, Animals, Humans, Purines metabolism, Signal Transduction physiology, Drug Therapy trends, Receptors, Purinergic metabolism, Receptors, Purinergic physiology
- Published
- 2019
- Full Text
- View/download PDF
22. Purinergic receptors in multiple sclerosis pathogenesis.
- Author
-
Domercq M, Zabala A, and Matute C
- Subjects
- Animals, Astrocytes metabolism, Brain metabolism, Central Nervous System physiology, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental pathology, Humans, Microglia pathology, Multiple Sclerosis pathology, Oligodendroglia metabolism, Receptors, Purinergic P2X metabolism, Receptors, Purinergic P2Y metabolism, Signal Transduction physiology, Multiple Sclerosis metabolism, Receptors, Purinergic metabolism, Receptors, Purinergic physiology
- Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, characterized by the presence of focal lesions in white and grey matter with peripheral immune cells infiltration. Purinergic receptors control immune cell function as well as neuronal and oligodendroglial survival, and the activation of astrocytes and microglia, the endogenous brain immune cells. In particular, ionotropic purinergic receptors P2X4 and P2X7 and metabotropic receptor P2Y12 are differently expressed along the disease and their activation or blockage modifies the course of texperimental autoimmune encephalomyelitis (EAE), the dominant animal model of MS. In this review, we will summarize emerging evidence of the role of these three receptor types as potential MS biomarkers and therapeutic targets., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
23. Purinergic signaling in the organ of Corti: Potential therapeutic targets of sensorineural hearing losses.
- Author
-
Berekméri E, Szepesy J, Köles L, and Zelles T
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Cochlea metabolism, Cochlea physiology, Hearing physiology, Hearing Loss physiopathology, Humans, Noise, Organ of Corti physiology, Purines metabolism, Receptors, Purinergic physiology, Receptors, Purinergic P1 metabolism, Receptors, Purinergic P1 physiology, Receptors, Purinergic P2 metabolism, Receptors, Purinergic P2 physiology, Signal Transduction drug effects, Hearing Loss metabolism, Organ of Corti metabolism, Receptors, Purinergic metabolism
- Abstract
Purinergic signaling is deeply involved in the development, functions and protective mechanisms of the cochlea. Release of ATP and activation of purinergic receptors on sensory and supporting/epithelial cells play a substantial role in cochlear (patho)physiology. Both the ionotropic P2X and the metabotropic P2Y receptors are widely distributed on the inner and outer hair cells as well as on the different supporting cells in the organ of Corti and on other epithelial cells in the scala media. Among others, they are implicated in the sensitivity adjustment of the receptor cells by a K
+ shunt and can attenuate the cochlear amplification by modifying cochlear micromechanics acting on outer hair cells and supporting cells. Cochlear blood flow is also regulated by purines. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy. Decreasing hearing sensitivity and increasing cochlear blood supply by pharmacological targeting of purinergic signaling in the cochlea are potential new therapeutic approaches in these hearing disabilities, especially in the noise-induced ones., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
24. Purinergic signaling in the retina: From development to disease.
- Author
-
Ventura ALM, Dos Santos-Rodrigues A, Mitchell CH, and Faillace MP
- Subjects
- Adenosine metabolism, Adenosine Triphosphate metabolism, Animals, Cell Death, Cell Differentiation, Humans, Purines, Receptors, Purinergic P2X metabolism, Receptors, Purinergic P2Y metabolism, Retina pathology, Signal Transduction physiology, Receptors, Purinergic metabolism, Receptors, Purinergic physiology, Retina metabolism
- Abstract
Retinal injuries and diseases are major causes of human disability involving vision impairment by the progressive and permanent loss of retinal neurons. During development, assembly of this tissue entails a successive and overlapping, signal-regulated engagement of complex events that include proliferation of progenitors, neurogenesis, cell death, neurochemical differentiation and synaptogenesis. During retinal damage, several of these events are re-activated with both protective and detrimental consequences. Purines and pyrimidines, along with their metabolites are emerging as important molecules regulating both retinal development and the tissue's responses to damage. The present review provides an overview of the purinergic signaling in the developing and injured retina. Recent findings on the presence of vesicular and channel-mediated ATP release by retinal and retinal pigment epithelial cells, adenosine synthesis and release, expression of receptors and intracellular signaling pathways activated by purinergic signaling in retinal cells are reported. The pathways by which purinergic receptors modulate retinal cell proliferation, migration and death of retinal cells during development and injury are summarized. The contribution of nucleotides to the self-repair of the injured zebrafish retina is also discussed., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
25. Pharmacological strategies for targeting platelet activation in asthma.
- Author
-
Pitchford S, Cleary S, Arkless K, and Amison R
- Subjects
- Animals, Anti-Inflammatory Agents therapeutic use, Antithrombins therapeutic use, Asthma physiopathology, Humans, Platelet Aggregation Inhibitors therapeutic use, Prostaglandin-Endoperoxide Synthases physiology, Purinergic Antagonists therapeutic use, Receptors, Purinergic physiology, Receptors, Thromboxane A2, Prostaglandin H2 physiology, Asthma drug therapy, Platelet Activation drug effects
- Abstract
The activation of platelets during host defence and inflammatory disorders has become increasingly documented. Clinical studies of patients with asthma reveal heightened platelet activation and accumulation into lung tissue. Accompanying studies in animal models of allergic lung inflammation, using protocols of experimentally induced thrombocytopenia proclaim an important role for platelets during the leukocyte recruitment cascade, tissue integrity, and lung function. The functions of platelets during these inflammatory events are clearly distinct to platelet functions during haemostasis and clot formation, and have led to the concept that a dichotomy (or polytomy, depending on what else platelets do) in platelet activation exists. The platelet, therefore, presents us with novel opportunities for modulating these inflammatory responses. This review discusses the rationale and effectiveness of current anti-platelet drugs in their use to supress inflammation with regard to asthma, and the need to consider novel possibilities for pharmacological modulation of platelet function associated with inflammation that are pharmacologically distinct to current anti-platelet therapies., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
26. Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.
- Author
-
Zhou Z, Matsumoto T, Jankowski V, Pernow J, Mustafa SJ, Duncker DJ, and Merkus D
- Subjects
- Animals, Cardiovascular System, Humans, Signal Transduction, Cardiovascular Physiological Phenomena, Dinucleoside Phosphates physiology, Receptors, Purinergic physiology
- Abstract
Uridine adenosine tetraphosphate (Up
4 A), biosynthesized by activation of vascular endothelial growth factor receptor (VEGFR) 2, was initially identified as a potent endothelium-derived vasoconstrictor in perfused rat kidney. Subsequently, the effect of Up4 A on vascular tone regulation was intensively investigated in arteries isolated from different vascular beds in rodents including rat pulmonary arteries, aortas, mesenteric and renal arteries as well as mouse aortas, in which Up4 A produces vascular contraction. In contrast, Up4 A produces vascular relaxation in porcine coronary small arteries and rat aortas. Intravenous infusion of Up4 A into conscious rats or mice decreases blood pressure, and intravenous bolus injection of Up4 A into anesthetized mice increases coronary blood flow, indicating an overall vasodilator influence in vivo. Although Up4 A is the first dinucleotide described that contains both purine and pyrimidine moieties, its cardiovascular effects are exerted mainly through activation of purinergic receptors. These effects not only encompass regulation of vascular tone, but also endothelial angiogenesis, smooth muscle cell proliferation and migration, and vascular calcification. Furthermore, this review discusses a potential role for Up4 A in cardiovascular pathophysiology, as plasma levels of Up4 A are elevated in juvenile hypertensive patients and Up4 A-mediated vascular purinergic signaling changes in cardiovascular disease such as hypertension, diabetes, atherosclerosis and myocardial infarction. Better understanding the vascular effect of the novel dinucleotide Up4 A and the purinergic signaling mechanisms mediating its effects will enhance its potential as target for treatment of cardiovascular disease., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
27. Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View.
- Author
-
Tibúrcio R, Nunes S, Nunes I, Rosa Ampuero M, Silva IB, Lima R, Machado Tavares N, and Brodskyn C
- Subjects
- Adaptive Immunity, Animals, Antigen Presentation, Cell Movement, Dendritic Cells classification, Dendritic Cells metabolism, Epigenesis, Genetic, Humans, Mice, Receptors, Purinergic physiology, Toll-Like Receptors physiology, Dendritic Cells immunology, Leishmaniasis immunology
- Abstract
Dendritic cells (DC) are a diverse group of leukocytes responsible for bridging innate and adaptive immunity. Despite their functional versatility, DCs exist primarily in two basic functional states: immature and mature. A large body of evidence suggests that upon interactions with pathogens, DCs undergo intricate cellular processes that culminate in their activation, which is paramount to the orchestration of effective immune responses against Leishmani a parasites. Herein we offer a concise review of the emerging hallmarks of DCs activation in leishmaniasis as well as a comprehensive discussion of the following underlying molecular events: DC- Leishmania interaction, antigen uptake, costimulatory molecule expression, parasite ability to affect DC migration, antigen presentation, metabolic reprogramming, and epigenetic alterations.
- Published
- 2019
- Full Text
- View/download PDF
28. Does the purinergic system affect extracellular matrix functions in the central nervous system?
- Author
-
Zuccarini M, Carluccio M, Ziberi S, Giuliani P, Buccella S, Conti C, Ciccarelli R, and Di Iorio P
- Subjects
- Humans, Brain physiology, Central Nervous System physiology, Extracellular Matrix physiology, Receptors, Purinergic physiology
- Abstract
Exracellular matrix (ECM) consists of a plethora of proteins and polysaccharides, which aggregate into an organized network connected to the surface of the producing cells. It is structurally and functionally present in all components of tissues and organs and represents the substrate on which cells adhere, migrate, proliferate and differentiate, influencing their survival, shape and function. In response to acute (trauma) or chronic (degenerative) insults, brain ECM modifies its composition and function, actively contributing to "scar forming" gliosis or tissue degeneration/remodelling. Moreover, morphological changes in dendritic spines associated with extracellular matrix remodeling play key roles in rewiring synaptic circuitry pertinent to memory formation. In the present report, we collected the main acquisitions on the functional interplay between ECM alterations and the adenine-/guaninebased purine system with particular regard on how purine compounds and their respective receptors may affect and be affected by changes of the cerebral ECM.
- Published
- 2018
29. The purinergic mechanism of the central nucleus of amygdala is involved in the modulation of salt intake in sodium-depleted rats.
- Author
-
Guan L, Qiao H, Wang N, Luo X, and Yan J
- Subjects
- Adenosine Triphosphate pharmacology, Animals, Bicuculline pharmacology, Central Amygdaloid Nucleus physiology, Drinking drug effects, Drinking Behavior drug effects, Feeding Behavior drug effects, Furosemide pharmacology, GABA-A Receptor Agonists pharmacology, GABA-A Receptor Antagonists pharmacology, Male, Muscimol pharmacology, Rats, Rats, Sprague-Dawley, Receptors, GABA-A metabolism, Receptors, Purinergic metabolism, Receptors, Purinergic physiology, Central Amygdaloid Nucleus drug effects, Central Amygdaloid Nucleus metabolism, Sodium metabolism
- Abstract
The central nucleus of the amygdala (CeA) is a critical region in regulating sodium intake, and interestingly, purinergic receptors reportedly related to fluid balance, are also expressed in CeA. In this study, we investigated whether the purinergic mechanisms of CeA were involved in regulating sodium intake. Male Sprague-Dawley rats had cannulas implanted bilaterally into the CeA and were sodium depleted with furosemide (FURO 20 mg/kg) plus 24 h-sodium deficient food fed. Bilateral injections of the P2X purinergic agonist, α,β-methyleneadenosine 5'-triphosphate (α,β-methylene ATP 1.0, 2.0, 4.0 nmol, respectively) into the CeA region induced dose-related reductions in sodium intake without affecting water intake. Injection of P2X purinergic antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS 4.0 nmol/0.5 μl) into the CeA region did not alter sodium and water intake, however, prior injection of PPADS into the CeA area abolished the inhibitory effects on sodium intake by α,β-methylene ATP. Interestingly, prior injection of γ-aminobutyric acid type A (GABA
A ) receptor antagonist, bicuculline (4.0 nmol/0.5 μl) into the CeA region partially reversed the deficit of sodium intake induced by α,β-methylene ATP. These results suggest that purinergic receptors in the CeA are involved in the control of sodium intake in the sodium-depleted rats and this negative modulation may be, at least partly, mediated by the GABAA receptor., (Copyright © 2018. Published by Elsevier Inc.)- Published
- 2018
- Full Text
- View/download PDF
30. The involvement of purinergic signalling in obesity.
- Author
-
Burnstock G and Gentile D
- Subjects
- Animals, Humans, Obesity metabolism, Obesity physiopathology, Receptors, Purinergic physiology, Signal Transduction physiology
- Abstract
Obesity is a growing worldwide health problem, with an alarming increasing prevalence in developed countries, caused by a dysregulation of energy balance. Currently, no wholly successful pharmacological treatments are available for obesity and related adverse consequences. In recent years, hints obtained from several experimental animal models support the notion that purinergic signalling, acting through ATP-gated ion channels (P2X), G protein-coupled receptors (P2Y) and adenosine receptors (P1), is involved in obesity, both at peripheral and central levels. This review has drawn together, for the first time, the evidence for a promising, much needed novel therapeutic purinergic signalling approach for the treatment of obesity with a 'proof of concept' that hopefully could lead to further investigations and clinical trials for the management of obesity.
- Published
- 2018
- Full Text
- View/download PDF
31. CALHM3 Is Essential for Rapid Ion Channel-Mediated Purinergic Neurotransmission of GPCR-Mediated Tastes.
- Author
-
Ma Z, Taruno A, Ohmoto M, Jyotaki M, Lim JC, Miyazaki H, Niisato N, Marunaka Y, Lee RJ, Hoff H, Payne R, Demuro A, Parker I, Mitchell CH, Henao-Mejia J, Tanis JE, Matsumoto I, Tordoff MG, and Foskett JK
- Subjects
- Animals, Calcium Channels analysis, Female, HEK293 Cells, HeLa Cells, Humans, Mice, Mice, Transgenic, Receptors, G-Protein-Coupled analysis, Receptors, Purinergic analysis, Synaptic Transmission physiology, Xenopus, Calcium Channels physiology, Ion Channel Gating physiology, Receptors, G-Protein-Coupled physiology, Receptors, Purinergic physiology, Taste physiology, Taste Perception physiology
- Abstract
Binding of sweet, umami, and bitter tastants to G protein-coupled receptors (GPCRs) in apical membranes of type II taste bud cells (TBCs) triggers action potentials that activate a voltage-gated nonselective ion channel to release ATP to gustatory nerves mediating taste perception. Although calcium homeostasis modulator 1 (CALHM1) is necessary for ATP release, the molecular identification of the channel complex that provides the conductive ATP-release mechanism suitable for action potential-dependent neurotransmission remains to be determined. Here we show that CALHM3 interacts with CALHM1 as a pore-forming subunit in a CALHM1/CALHM3 hexameric channel, endowing it with fast voltage-activated gating identical to that of the ATP-release channel in vivo. Calhm3 is co-expressed with Calhm1 exclusively in type II TBCs, and its genetic deletion abolishes taste-evoked ATP release from taste buds and GPCR-mediated taste perception. Thus, CALHM3, together with CALHM1, is essential to form the fast voltage-gated ATP-release channel in type II TBCs required for GPCR-mediated tastes., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
32. Development of contractile properties in the fetal porcine urinary bladder.
- Author
-
Jakobsen LK, Trelborg KF, Simonsen U, Andersson KE, and Olsen LH
- Subjects
- Adenosine Triphosphate analogs & derivatives, Adenosine Triphosphate physiology, Animals, Electromagnetic Fields, Female, In Vitro Techniques, Isometric Contraction physiology, Male, Muscle Development, Muscle, Smooth physiology, Potassium Chloride chemistry, Pregnancy, Pregnancy, Animal, Receptors, Purinergic physiology, Stress, Mechanical, Swine, Urinary Bladder physiology, Muscle Contraction physiology, Muscle, Smooth embryology, Urinary Bladder embryology
- Abstract
BackgroundIn early fetal life, the bladder is merely a conduit allowing urine to pass through freely into the amniotic cavity. As the striated external urethral sphincter evolves, the bladder acquires its reservoir and voiding functions. We characterized the myogenic and neurogenic contractions of the normal fetal porcine bladder from midterm until close to full-term gestation.MethodsContractile responses were measured in vitro using bladder strips from fetuses at 60 (N=23) and 100 days (N=21) of gestation. Spontaneous activity, and the responses to potassium chloride (KCl) solution, electrical field stimulation (EFS), and receptor activation were recorded. The smooth muscle content was evaluated histologically.ResultsHistological studies revealed that the fractional content of smooth muscle doubled between the two time points, and passive tension was adjusted to take that into account. Spontaneous activity was regular at 60 days, changing toward an irregular pattern at 100 days. Contractile force elicited by KCl and carbachol increased significantly with gestational age, while contractions to the purinergic agonist, α-β-methylene adenosine 5'-triphosphate did not. The responses to EFS were almost completely blocked by atropine.ConclusionSpontaneous myogenic contractions become irregular and contractile responses to muscarinic receptor stimulation increase during gestation, as the bladder reservoir and voiding functions develop.
- Published
- 2018
- Full Text
- View/download PDF
33. Tackling Chronic Pain and Inflammation through the Purinergic System.
- Author
-
Magni G, Riccio D, and Ceruti S
- Subjects
- Adenosine metabolism, Adenosine Triphosphate metabolism, Analgesics pharmacology, Animals, Anti-Inflammatory Agents pharmacology, Humans, Purinergic Agonists pharmacology, Purinergic Antagonists pharmacology, Receptors, Purinergic metabolism, Receptors, Purinergic physiology, Signal Transduction drug effects, Analgesics therapeutic use, Anti-Inflammatory Agents therapeutic use, Chronic Pain drug therapy, Inflammation drug therapy, Purinergic Agonists therapeutic use, Purinergic Antagonists therapeutic use
- Abstract
The purinergic system is composed of purine and pyrimidine transmitters, the enzymes that modulate the interconversion of nucleotides and nucleosides, the membrane transporters that control their extracellular concentrations, and the many receptor subtypes that are responsible for their cellular responses. The components of this system are ubiquitously localized in all tissues and organs, and their involvement in several physiological conditions has been clearly demonstrated. Moreover, extracellular purine and pyrimidine concentrations rise several folds under pathological conditions like tissue damage, ischemia, and inflammation, which suggest that this signaling system might contribute both to disease outcome and, possibly, to its tentative resolution. The complexity of this system has greatly impaired the clear identification of the mediators and receptors that are actually involved in a given pathology, also due to the often opposite roles played by the various receptor subtypes. Nevertheless, this knowledge is fundamental for the possible exploitation of these molecular entities as targets for the development of new pharmacological approaches. In this review, we aim at highlighting what is currently known on the role of the purinergic system in various pain conditions and during inflammatory processes. Although some confusion may arise from conflicting results, literature data clearly show that targeting specific purinergic receptors may represent an innovative approach to various pain and inflammatory conditions, and that new purine-based drugs are now very close to reach the market with these indications., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Published
- 2018
- Full Text
- View/download PDF
34. Dedication of Special Issue on Purinergic Regulation in the Eye to Mortimer M. Civan.
- Author
-
Mitchell CH and Stamer WD
- Subjects
- Anniversaries and Special Events, Eye drug effects, History, 20th Century, History, 21st Century, Humans, Purinergic Agonists pharmacology, Purinergic Antagonists pharmacology, Ocular Physiological Phenomena drug effects, Receptors, Purinergic physiology
- Published
- 2016
- Full Text
- View/download PDF
35. Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
- Author
-
Beckel JM, Lu W, Civan MM, and Mitchell CH
- Subjects
- Animals, Humans, Retina drug effects, Retina physiology, Signal Transduction drug effects, Signal Transduction physiology, Treatment Outcome, Purinergic Agonists administration & dosage, Purinergic Antagonists administration & dosage, Receptors, Purinergic physiology, Retinal Diseases drug therapy
- Published
- 2016
- Full Text
- View/download PDF
36. Purinergic signaling in testes revealed.
- Author
-
Björkgren I and Lishko PV
- Subjects
- Animals, Male, Mice, Signal Transduction physiology, Spermatogenesis, Receptors, Purinergic physiology, Testis physiology
- Published
- 2016
- Full Text
- View/download PDF
37. Relationship between intracellular calcium and morphologic changes in rabbit erythrocytes: Effects of the acylated and unacylated forms of E. coli alpha-hemolysin.
- Author
-
Vázquez RF, Maté SM, Bakás LS, Muñoz-Garay C, and Herlax VS
- Subjects
- Acylation, Adenosine Triphosphate pharmacology, Animals, Calcium Signaling drug effects, Cell Shape drug effects, Erythrocyte Membrane drug effects, Erythrocytes ultrastructure, Escherichia coli Proteins chemistry, Hemolysin Proteins chemistry, Intracellular Fluid chemistry, Ion Transport, Protein Processing, Post-Translational, Rabbits, Receptors, Purinergic physiology, Time-Lapse Imaging, Calcium metabolism, Erythrocytes chemistry, Escherichia coli Proteins pharmacology, Hemolysin Proteins pharmacology
- Published
- 2016
- Full Text
- View/download PDF
38. Purinergic signalling underlies transforming growth factor-β-mediated bladder afferent nerve hyperexcitability.
- Author
-
Gonzalez EJ, Heppner TJ, Nelson MT, and Vizzard MA
- Subjects
- Animals, Connexins physiology, Cyclophosphamide, Cystitis chemically induced, Male, Mice, Inbred C57BL, Nerve Tissue Proteins physiology, Protein Serine-Threonine Kinases physiology, Purinergic Antagonists pharmacology, Pyridoxal Phosphate analogs & derivatives, Pyridoxal Phosphate pharmacology, Receptor, Transforming Growth Factor-beta Type I, Receptors, Transforming Growth Factor beta physiology, Signal Transduction, Urothelium physiology, Adenosine Triphosphate physiology, Cystitis physiopathology, Receptors, Purinergic physiology, Transforming Growth Factor beta physiology, Urinary Bladder innervation, Urinary Bladder physiology
- Abstract
Key Points: The sensory components of the urinary bladder are responsible for the transduction of bladder filling and are often impaired with neurological injury or disease. Elevated extracellular ATP contributes, in part, to bladder afferent nerve hyperexcitability during urinary bladder inflammation or irritation. Transforming growth factor-β1 (TGF-β1) may stimulate ATP release from the urothelium through vesicular exocytosis mechanisms with minimal contribution from pannexin-1 channels to increase bladder afferent nerve discharge. Bladder afferent nerve hyperexcitability and urothelial ATP release with CYP-induced cystitis is decreased with TGF-β inhibition. These results establish a causal link between an inflammatory mediator, TGF-β, and intrinsic signalling mechanisms of the urothelium that may contribute to the altered sensory processing of bladder filling., Abstract: The afferent limb of the micturition reflex is often compromised following bladder injury, disease and inflammatory conditions. We have previously demonstrated that transforming growth factor-β (TGF-β) signalling contributes to increased voiding frequency and decreased bladder capacity with cystitis. Despite the functional presence of TGF-β in bladder inflammation, the precise mechanisms of TGF-β mediating bladder dysfunction are not yet known. Thus, the present studies investigated the sensory components of the urinary bladder that may underlie the pathophysiology of aberrant TGF-β activation. We utilized bladder-pelvic nerve preparations to characterize bladder afferent nerve discharge and the mechanisms of urothelial ATP release with distention. Our findings indicate that bladder afferent nerve discharge is sensitive to elevated extracellular ATP during pathological conditions of urinary bladder inflammation or irritation. We determined that TGF-β1 may increase bladder afferent nerve excitability by stimulating ATP release from the urothelium via vesicular exocytosis mechanisms with minimal contribution from pannexin-1 channels. Furthermore, blocking aberrant TGF-β signalling in cyclophosphamide-induced cystitis with TβR-1 inhibition decreased afferent nerve hyperexcitability with a concomitant decrease in urothelial ATP release. Taken together, these results establish a role for purinergic signalling mechanisms in TGF-β-mediated bladder afferent nerve activation that may ultimately facilitate increased voiding frequency. The synergy between intrinsic urinary bladder signalling mechanisms and an inflammatory mediator provides novel insight into bladder dysfunction and supports new avenues for therapeutic intervention., (© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.)
- Published
- 2016
- Full Text
- View/download PDF
39. Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.
- Author
-
Köles L, Kató E, Hanuska A, Zádori ZS, Al-Khrasani M, Zelles T, Rubini P, and Illes P
- Subjects
- Animals, Humans, Receptors, AMPA physiology, Receptors, N-Methyl-D-Aspartate physiology, Neuroglia metabolism, Neurons metabolism, Receptors, Glutamate physiology, Receptors, Purinergic physiology, Signal Transduction physiology, Synaptic Transmission physiology
- Abstract
Glutamate is the main excitatory neurotransmitter of the central nervous system (CNS), released both from neurons and glial cells. Acting via ionotropic (NMDA, AMPA, kainate) and metabotropic glutamate receptors, it is critically involved in essential regulatory functions. Disturbances of glutamatergic neurotransmission can be detected in cognitive and neurodegenerative disorders. This paper summarizes the present knowledge on the modulation of glutamate-mediated responses in the CNS. Emphasis will be put on NMDA receptor channels, which are essential executive and integrative elements of the glutamatergic system. This receptor is crucial for proper functioning of neuronal circuits; its hypofunction or overactivation can result in neuronal disturbances and neurotoxicity. Somewhat surprisingly, NMDA receptors are not widely targeted by pharmacotherapy in clinics; their robust activation or inhibition seems to be desirable only in exceptional cases. However, their fine-tuning might provide a promising manipulation to optimize the activity of the glutamatergic system and to restore proper CNS function. This orchestration utilizes several neuromodulators. Besides the classical ones such as dopamine, novel candidates emerged in the last two decades. The purinergic system is a promising possibility to optimize the activity of the glutamatergic system. It exerts not only direct and indirect influences on NMDA receptors but, by modulating glutamatergic transmission, also plays an important role in glia-neuron communication. These purinergic functions will be illustrated mostly by depicting the modulatory role of the purinergic system on glutamatergic transmission in the prefrontal cortex, a CNS area important for attention, memory and learning.
- Published
- 2016
- Full Text
- View/download PDF
40. Differential Modulation of GABAA Receptors Underlies Postsynaptic Depolarization- and Purinoceptor-Mediated Enhancement of Cerebellar Inhibitory Transmission: A Non-Stationary Fluctuation Analysis Study.
- Author
-
Ono Y, Saitow F, and Konishi S
- Subjects
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine analogs & derivatives, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine pharmacology, Adenosine Triphosphate pharmacology, Animals, Cerebellum drug effects, Female, Isoquinolines pharmacology, Male, Patch-Clamp Techniques, Protein Kinase Inhibitors pharmacology, Purkinje Cells drug effects, Purkinje Cells physiology, Rats, Rats, Wistar, Receptors, GABA-A drug effects, Signal Transduction drug effects, Signal Transduction physiology, Sulfonamides pharmacology, Synapses drug effects, Synapses physiology, Synaptic Potentials drug effects, Cerebellum physiology, Receptors, GABA-A physiology, Receptors, Purinergic physiology, Synaptic Potentials physiology
- Abstract
Cerebellar GABAergic inhibitory transmission between interneurons and Purkinje cells (PCs) undergoes a long-lasting enhancement following different stimulations, such as brief depolarization or activation of purinergic receptors of postsynaptic PCs. The underlying mechanisms, however, are not completely understood. Using a peak-scaled non-stationary fluctuation analysis, we therefore aimed at characterizing changes in the electrophysiological properties of GABAA receptors in PCs of rat cerebellar cortex during depolarization-induced "rebound potentiation (RP)" and purinoceptor-mediated long-term potentiation (PM-LTP), because both RP and PM-LTP likely depend on postsynaptic mechanisms. Stimulation-evoked inhibitory postsynaptic currents (eIPSCs) were recorded from PCs in neonatal rat cerebellar slices. Our analysis showed that postsynaptic membrane depolarization induced RP of eIPSCs in association with significant increase in the number of synaptic GABAA receptors without changing the channel conductance. By contrast, bath application of ATP induced PM-LTP of eIPSCs with a significant increase of the channel conductance of GABAA receptors without affecting the receptor number. Pretreatment with protein kinase A (PKA) inhibitors, H-89 and cAMPS-Rp, completely abolished the PM-LTP. The CaMKII inhibitor KN-62 reported to abolish RP did not alter PM-LTP. These results suggest that the signaling mechanism underlying PM-LTP could involve ATP-induced phosphorylation of synaptic GABAA receptors, thereby resulting in upregulation of the channel conductance by stimulating adenylyl cyclase-PKA signaling cascade, possibly via activation of P2Y11 purinoceptor. Thus, our findings reveal that postsynaptic GABAA receptors at the interneuron-PC inhibitory synapses are under the control of two distinct forms of long-term potentiation linked with different second messenger cascades.
- Published
- 2016
- Full Text
- View/download PDF
41. Mitochondrial Dysfunction, Depleted Purinergic Signaling, and Defective T Cell Vigilance and Immune Defense.
- Author
-
Ledderose C, Bao Y, Ledderose S, Woehrle T, Heinisch M, Yip L, Zhang J, Robson SC, Shapiro NI, and Junger WG
- Subjects
- Adolescent, Adult, Humans, Jurkat Cells, Suramin, Young Adult, CD4-Positive T-Lymphocytes physiology, Calcium Signaling physiology, Mitochondria physiology, Purines metabolism, Receptors, Purinergic physiology, Sepsis immunology
- Abstract
T cell suppression in sepsis is a well-known phenomenon; however, the underlying mechanisms are not fully understood. Previous studies have shown that T cell stimulation up-regulates mitochondrial adenosine triphosphate (ATP) production to fuel purinergic signaling mechanisms necessary for adequate T cell responses. Here we show that basal mitochondrial ATP production, ATP release, and stimulation of P2X1 receptors represent a standby purinergic signaling mechanism that is necessary for antigen recognition. Inhibition of this process impairs T cell vigilance and the ability of T cells to trigger T cell activation, up-regulate mitochondrial ATP production, and stimulate P2X4 and P2X7 receptors that elicit interleukin 2 production and T cell proliferation. T cells of patients with sepsis lack this standby purinergic signaling system owing to defects in mitochondrial function, ATP release, and calcium signaling. These defects impair antigen recognition and T cell function and are correlated with sepsis severity. Pharmacological targeting of these defects may improve T cell function and reduce the risk of sepsis., (© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
42. Dura-evoked neck muscle activity involves purinergic and N-methyl-D-aspartate receptor mechanisms.
- Author
-
Yao D, Yoshida M, and Sessle BJ
- Subjects
- Adenosine Triphosphate analogs & derivatives, Adenosine Triphosphate pharmacology, Animals, Dura Mater drug effects, Electromyography, Male, Medulla Oblongata drug effects, Purinergic Agonists pharmacology, Purinergic Antagonists pharmacology, Rats, Sprague-Dawley, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Dura Mater physiology, Neck Muscles physiology, Receptors, N-Methyl-D-Aspartate physiology, Receptors, Purinergic physiology
- Abstract
We have previously demonstrated that noxious stimulation of craniofacial tissues including the frontal dura reflexly evokes significant increases in neck muscle electromyographic (EMG) activity. The primary aim of this study was to determine whether purinergic receptor mechanisms may be involved in these EMG effects, and whether N-methyl-D-aspartate (NMDA) receptor processes modulate the purinergic mechanisms. Application of the P2X1, P2X3 and P2X2/3 receptor agonist α,β-methylene ATP (but not vehicle) to the dural surface evoked a significant (P<0.05) increase in ipsilateral neck EMG activity that could be suppressed by dural or intrathecal application of the selective P2X1, P2X3 and P2X2/3 receptor antagonist 2',3'-O-(2,4,6-trinitrophenyl) ATP (TNP-ATP) but not by vehicle; the intrathecal application of 2-amino-5-phosphonopentanoic acid, an NMDA receptor antagonist, also significantly reduced the neck EMG activity evoked by dural application of α,β-methylene ATP. These data suggest that purinergic receptor mechanisms contribute to the increased neck activity that can be reflexly evoked by noxious stimulation of the frontal dura, and that NMDA as well as purinergic receptor mechanisms in the medulla may modulate these purinergic-related effects.
- Published
- 2015
- Full Text
- View/download PDF
43. Blood cells: an historical account of the roles of purinergic signalling.
- Author
-
Burnstock G
- Subjects
- Adenosine Diphosphate physiology, Adenosine Triphosphate blood, Animals, Blood Platelets metabolism, Blood Platelets physiology, Humans, Platelet Aggregation physiology, Blood Cells physiology, Receptors, Purinergic blood, Receptors, Purinergic physiology, Signal Transduction physiology
- Abstract
The involvement of purinergic signalling in the physiology of erythrocytes, platelets and leukocytes was recognised early. The release of ATP and the expression of purinoceptors and ectonucleotidases on erythrocytes in health and disease are reviewed. The release of ATP and ADP from platelets and the expression and roles of P1, P2Y(1), P2Y(12) and P2X1 receptors on platelets are described. P2Y(1) and P2X(1) receptors mediate changes in platelet shape, while P2Y(12) receptors mediate platelet aggregation. The changes in the role of purinergic signalling in a variety of disease conditions are considered. The successful use of P2Y(12) receptor antagonists, such as clopidogrel and ticagrelor, for the treatment of thrombosis, myocardial infarction and stroke is discussed.
- Published
- 2015
- Full Text
- View/download PDF
44. The role of purinergic and dopaminergic systems on MK-801-induced antidepressant effects in zebrafish.
- Author
-
da Silva RB, Siebel AM, and Bonan CD
- Subjects
- Adenosine physiology, Adenosine A1 Receptor Agonists pharmacology, Adenosine A1 Receptor Antagonists pharmacology, Adenosine A2 Receptor Agonists pharmacology, Adenosine A2 Receptor Antagonists pharmacology, Animals, Antidepressive Agents administration & dosage, Behavior, Animal drug effects, Behavior, Animal physiology, Dizocilpine Maleate administration & dosage, Dopamine Antagonists pharmacology, Dopaminergic Neurons drug effects, Dopaminergic Neurons physiology, Receptors, Purinergic drug effects, Receptors, Purinergic physiology, Antidepressive Agents pharmacology, Dizocilpine Maleate pharmacology, Zebrafish physiology
- Abstract
Depression is a serious disease characterized by low mood, anhedonia, loss of interest in daily activities, appetite and sleep disturbances, reduced concentration, and psychomotor agitation. There is a growing interest in NMDA antagonists as a promising target for the development of new antidepressants. Considering that purinergic and dopaminergic systems are involved in depression and anxiety states, we characterized the role of these signaling pathways on MK-801-induced antidepressant effects in zebrafish. Animals treated with MK-801 at the doses of 5, 10, 15, or 20μM during 15, 30, or 60min spent longer time in the top area of aquariums in comparison to control group, indicating an anxiolytic/antidepressant effect induced by this drug. Animals treated with MK-801 spent longer time period at top area until 2 (5μM MK-801) and 4 (20μM MK-801) hours after treatment, returning to basal levels from 24h to 7days after exposure. Repeated MK-801 treatment did not induce cumulative effects, since animals treated daily during 7days had the same behavioral response pattern observed since the first until the 7th day. In order to investigate the effects of adenosine A1 and A2A receptor antagonist and agonist and the influence of modulation of adenosine levels on MK-801 effects, we treated zebrafish with caffeine, DPCPX, CPA, ZM 241385, CGS 21680, AMPCP, EHNA, dipyridamole, and NBTI during 30min before MK-801 exposure. The non-specific adenosine receptor antagonist caffeine (50mg/kg) and the selective A1 receptor antagonist DPCPX (15mg/kg) prevented the behavioral changes induced by MK-801. The non-specific nucleoside transporter (NT) inhibitor dipyridamole (10mg/kg) exacerbated the behavioral changes induced by MK-801. Dopamine receptor antagonists (sulpiride and SCH 23390) did not change the behavioral alterations induced by MK-801. Our findings demonstrated that antidepressant-like effects of MK-801 in zebrafish are mediated through adenosine A1 receptor activation., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
45. The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment.
- Author
-
Cieślak M, Czarnecka J, Roszek K, and Komoszyński M
- Subjects
- Adenosine Triphosphate metabolism, Animals, Cortical Spreading Depression drug effects, Humans, Receptors, Purinergic drug effects, Signal Transduction genetics, Migraine Disorders drug therapy, Migraine Disorders physiopathology, Receptors, Purinergic physiology, Signal Transduction physiology
- Abstract
Etiopathogenesis of migraine involves different structures of the central nervous system: the trigeminal nerve with nuclei located in the brain stem, vascular system, and the cerebral cortex as well as diverse mechanisms and pathological processes. The multidirectional action of purines in different cell types (blood vessels, neurons, and satellite glial cells) and through different types of purinergic receptors contributes to the etiopathogenesis of migraine pain. Adenosine triphosphate (ATP) and its derivatives are involved in initiation and propagation of migrenogenic signals in several ways: they participate in vasomotor mechanism, cortical spreading depression, and in fast transmission or cross-excitation based on the satellite glial cells in trigeminal ganglion. Contribution of purinergic signaling in the conduction of pain is realized through the activation of P1 and P2 receptors expressed widely in the central nervous system: on the neurons and glial cells as well as on the smooth muscles and endothelium in the vascular system. Therefore, the purinergic receptors can be an excellent target for pharmacologists constructing new antimigraine therapeutics. Moreover, the mechanisms facilitating ATP and adenosine degradation may prevent vasodilatation and thus avoid a secondary central sensitization during a migraine attack. Thus, agonists and antagonists of P receptors as well as ecto-enzymes metabolizing nucleotides/nucleosides could gain the growing attention as therapeutic agents.
- Published
- 2015
- Full Text
- View/download PDF
46. Purinergic signalling during development and ageing.
- Author
-
Burnstock G and Dale N
- Subjects
- Adult, Animals, Embryonic Development, Female, Humans, Pregnancy, Stem Cells physiology, Aging physiology, Purines, Receptors, Purinergic physiology, Signal Transduction physiology
- Abstract
Extracellular purines and pyrimidines play major roles during embryogenesis, organogenesis, postnatal development and ageing in vertebrates, including humans. Pluripotent stem cells can differentiate into three primary germ layers of the embryo but may also be involved in plasticity and repair of the adult brain. These cells express the molecular components necessary for purinergic signalling, and their developmental fates can be manipulated via this signalling pathway. Functional P1, P2Y and P2X receptor subtypes and ectonucleotidases are involved in the development of different organ systems, including heart, blood vessels, skeletal muscle, urinary bladder, central and peripheral neurons, retina, inner ear, gut, lung and vas deferens. The importance of purinergic signalling in the ageing process is suggested by changes in expression of A1 and A2 receptors in old rat brains and reduction of P2X receptor expression in ageing mouse brain. By contrast, in the periphery, increases in expression of P2X3 and P2X4 receptors are seen in bladder and pancreas.
- Published
- 2015
- Full Text
- View/download PDF
47. Nucleotide modulates odor response through activation of purinergic receptor in olfactory sensory neuron.
- Author
-
Yu Y
- Subjects
- Animals, Calcium metabolism, Mice, Mice, Inbred C57BL, Purinergic Agonists pharmacology, Sensory Receptor Cells drug effects, Sensory Receptor Cells metabolism, Adenosine Triphosphate physiology, Odorants, Receptors, Purinergic physiology, Sensory Receptor Cells physiology, Uridine Triphosphate physiology
- Abstract
Extracellular nucleotides are important neurotransmitters, neuromodulators and paracrine factors in the neural sensory system [16]. Most of purines and pyrimidines act on the associated purinergic cell-surface receptors to mediate sensory transduction and modulation. Previously, we reported a subgroup of heptaldehyde (H)/2-hepatanone (Ho)-responsive olfactory sensory neurons (H/Ho-OSNs) in the ventral endoturbinates [31]. Through the calcium image recording, we characterized that ATP elicited [Ca(2+)]i increase in the presence of extracellular calcium, while depletion of intracellular calcium stores blocked UTP-evoked [Ca(2+)]i increase. Pharmacological studies indicated that P2X3 was expressed in the H/Ho-OSNs, modulating both heptaldehyde (H) and 2-hepatanone (Ho)-induced responses. These data indicated that activation of purinergic receptor negatively modulated odor response, providing the evidence to support the possible protective effect of purinergic receptor in OSNs., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
48. Vasopressin and disruption of calcium signalling in polycystic kidney disease.
- Author
-
Chebib FT, Sussman CR, Wang X, Harris PC, and Torres VE
- Subjects
- Animals, Cyclic AMP physiology, Disease Models, Animal, Endoplasmic Reticulum, Humans, Receptors, Purinergic physiology, Sarcoplasmic Reticulum, TRPP Cation Channels physiology, Calcium Signaling physiology, Polycystic Kidney, Autosomal Dominant etiology, Vasopressins physiology
- Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic kidney disease and is responsible for 5-10% of cases of end-stage renal disease worldwide. ADPKD is characterized by the relentless development and growth of cysts, which cause progressive kidney enlargement associated with hypertension, pain, reduced quality of life and eventual kidney failure. Mutations in the PKD1 or PKD2 genes, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively, cause ADPKD. However, neither the functions of these proteins nor the molecular mechanisms of ADPKD pathogenesis are well understood. Here, we review the literature that examines how reduced levels of functional PC1 or PC2 at the primary cilia and/or the endoplasmic reticulum directly disrupts intracellular calcium signalling and indirectly disrupts calcium-regulated cAMP and purinergic signalling. We propose a hypothetical model in which dysregulated metabolism of cAMP and purinergic signalling increases the sensitivity of principal cells in collecting ducts and of tubular epithelial cells in the distal nephron to the constant tonic action of vasopressin. The resulting magnified response to vasopressin further enhances the disruption of calcium signalling that is initiated by mutations in PC1 or PC2, and activates downstream signalling pathways that cause impaired tubulogenesis, increased cell proliferation, increased fluid secretion and interstitial inflammation.
- Published
- 2015
- Full Text
- View/download PDF
49. Exaggerated increases in blood pressure during isometric muscle contraction in hypertension: role for purinergic receptors.
- Author
-
Greaney JL, Wenner MM, and Farquhar WB
- Subjects
- Animals, Baroreflex, Humans, Blood Pressure physiology, Hypertension physiopathology, Isometric Contraction physiology, Receptors, Purinergic physiology
- Abstract
Physical activity is a cornerstone therapy for the primary prevention and treatment of hypertension, which is becoming increasingly prevalent in modern societies. During exercise, heart rate and blood pressure (BP) increase in order to acutely meet the metabolic demands of the working skeletal muscle. In hypertensive adults, isometric exercise-induced increases in BP are excessive, potentially increasing the risk of an acute cardiovascular event during or after physical activity. Recently, the skeletal muscle metaboreflex has emerged as a significant contributor to the development of aberrant cardiovascular control during isometric exercise in this clinical population. Our laboratory has conducted a series of studies characterizing the skeletal muscle metaboreflex in hypertensive humans. We and others have demonstrated that hypertension is characterized by greater increases in muscle sympathetic nerve activity and BP during selective activation of the metaboreflex during post-exercise muscle ischemia compared to the increases noted in healthy age-matched normotensive adults, suggesting that the skeletal muscle metaboreflex is exaggerated in human hypertension. The focus of this review is the skeletal muscle metaboreflex (i.e., the metabolic component of the exercise pressor reflex) in hypertension, with particular emphasis on the potential role of purinergic receptors in mediating the exaggerated responses to muscle metaboreflex activation., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
50. [Hetero-oligomerization and Functional Interaction between Purinergic Receptors Expressed in Platelets to Regulate Platelet Shape Change].
- Author
-
Suzuki T
- Subjects
- Adenosine Diphosphate physiology, Dimerization, Humans, Platelet Aggregation physiology, Receptor Cross-Talk physiology, Receptor, Adenosine A2A physiology, Receptors, Purinergic analysis, Receptors, Purinergic P2Y1 physiology, Receptors, Purinergic P2Y12 physiology, Blood Platelets chemistry, Blood Platelets cytology, Receptors, Purinergic physiology
- Abstract
Adenosine and its precursors, ATP and ADP, exert various physiological effects via binding to purinergic receptors. We previously used co-immunoprecipitation, bioluminescence resonance energy transfer (BRET) and immunoelectron microscopy to demonstrate the hetero-oligomerization of purinergic receptor subtypes. Furthermore, pharmacological studies found significant changes in receptor-mediated signaling in human embryonic kidney (HEK) 293T cells co-transfected with these receptors. These findings suggest that heterodimers of purinergic receptors may have distinct pharmacological profiles, possibly due to dimerization-induced conformational changes, further suggesting that hetero-dimerization may be employed to "fine-tune" purinergic receptor signaling. Adenosine A(2A) receptor (A(2A)R), P2Y1 receptor (P2Y1R) and P2Y12 receptor (P2Y12R) are predominantly expressed on human platelets. ADP activates human platelets by stimulating both P2Y1R and P2Y12R, which act sequentially and in concert to achieve complete platelet aggregation. In contrast, adenosine stimulates Gs-coupled A(2A)R, followed by activativation of adenylate cyclase, leading to an increase in intracellular cAMP levels, which potently inhibits platelet activation. We examined the hetero-oligomerization and functional interactions of A(2A)R, P2Y1R, and P2Y12R. In HEK293T cells triply expressing all three receptors, hetero-oligomerization was observed among the three receptors. Additionally, P2Y1R agonist-evoked Ca(2+) signaling was significantly inhibited by co-treatment with an A(2A)R antagonist in HEK293T cells. In human platelets, we identified endogenous A(2A)R/P2Y1R and A(2A)R/P2Y12R heterodimers. We also observed functional Ca(2+)-signaling-related cross-talk similar to those found in HEK293T cells, and found that they appeared to affect platelet shape. These results collectively suggest that intermolecular signal transduction and specific conformational changes occur among components of the hetero-oligomers formed by these three receptors.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.